Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime vs Ceftazidime for Neutropenic Fever in Pediatric Leukemia
NCT04187755Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of cefepime in febrile neutropenia (FN) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Temperature decrease at 72 hours and Increase of Absolute Neutrophil Count at 72 hours. Started Mar 2019; status: completed.
02
Drugs
cefepime
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT04187755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187755.